Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives
 
Yazarlar (7)
Bathélémy Ngameni Université De Yaoundé I, Kamerun
Kamdoum Cedric Université De Yaoundé I, Kamerun
Armelle T. Mbaveng
University Of Dschang, Kamerun
Doç. Dr. Musa ERDOĞAN Kafkas Üniversitesi, Türkiye
Ingrid Simo
University Of Dschang, Kamerun
Victor Kuete
University Of Dschang, Kamerun
Arif Daştan Atatürk Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Bioorganic and Medicinal Chemistry Letters (Q2)
Dergi ISSN 0960-894X Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 03-2021
Cilt / Sayı / Sayfa 35 / 1 / 127827–0 DOI 10.1016/j.bmcl.2021.127827
Makale Linki http://dx.doi.org/10.1016/j.bmcl.2021.127827
Özet
A new series of O-substituted chalcone derivatives bearing an/a allyl-, prenyl- or propargyl-substituent at different positions of rings A and B and their derivatives as drug leads, was designed, synthesized, and characterized. The chalcone derivatives were synthesized via base catalyzed Claisen-Schmidt condensation in MeOH or EtOH solutions of appropriately substituted aromatic ketones with O-allyl, and O-propargylvanillin, respectively. The intermediates O-substituted phenylketone derivatives were firstly synthesized by nucleophilic substitution reaction. All the newly synthesized compounds were characterized by IR, NMR spectral data and elemental analyses. A preliminary cytotoxicity was performed with the compounds (1a, 1b, 2a, 2b, 3a, 3b, 4a, 5a-f, 6a-d, 7a-d) and the positive control, doxorubicin towards CCRF-CEM leukemia cells. Amongst them, compounds 1a, 2a, 5b-d, 6b, 7a, 7c and doxorubicin …
Anahtar Kelimeler
4-O-substituted chalcones | 4-O-substituted phenylcarbonyls | Anticancer activity | Claisen-Schmidt condensation | Nucleophilic O-substitution reaction | Synthesis